Sonova (OTCMKTS:SONVY) Shares Gap Up After Analyst Upgrade

Sonova Holding (OTCMKTS:SONVY)’s stock price gapped up prior to trading on Tuesday after BNP Paribas Exane upgraded the stock from a strong sell rating to a strong-buy rating. The stock had previously closed at $49.54, but opened at $52.70. Sonova shares last traded at $51.99, with a volume of 49,820 shares trading hands.

SONVY has been the subject of a number of other research reports. Royal Bank Of Canada upgraded Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Sonova Stock Performance

The company has a 50 day simple moving average of $52.79 and a 200-day simple moving average of $53.75. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.